5,000,000 Shares of Common Stock DYNAVAX TECHNOLOGIES CORPORATION UNDERWRITING AGREEMENT October 10, 2005Underwriting Agreement • October 12th, 2005 • Dynavax Technologies Corp • Pharmaceutical preparations • New York
Contract Type FiledOctober 12th, 2005 Company Industry JurisdictionBEAR, STEARNS & CO. INC. CIBC WORLD MARKETS CORP. PACIFIC GROWTH EQUITIES, LLC As Representatives of the several Underwriters named in Schedule I attached hereto (the “Representative(s)”) c/o Bear, Stearns & Co. Inc. 383 Madison Avenue New York, New York 10179
4,000,000 Shares of Common Stock CURAGEN CORPORATION UNDERWRITING AGREEMENT August 9, 2005Underwriting Agreement • August 10th, 2005 • Curagen Corp • Services-commercial physical & biological research • New York
Contract Type FiledAugust 10th, 2005 Company Industry JurisdictionCuraGen Corporation, a corporation organized and existing under the laws of Delaware (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Bear, Stearns & Co. Inc. (the “Underwriter”) an aggregate of 4,000,000 shares (the “Shares”) of its common stock, par value $0.01 per share (the “Common Stock”). The Shares are more fully described in the Registration Statement and Prospectus referred to below.
] Shares of Common Stock CKX, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • May 19th, 2005 • CKX, Inc. • Services-motion picture & video tape production • New York
Contract Type FiledMay 19th, 2005 Company Industry Jurisdiction
5,000,000 Shares of Common Stock GARDNER DENVER, INC. UNDERWRITING AGREEMENT April 28, 2005Underwriting Agreement • May 4th, 2005 • Gardner Denver Inc • General industrial machinery & equipment • New York
Contract Type FiledMay 4th, 2005 Company Industry JurisdictionBEAR, STEARNS & CO. INC. J.P. MORGAN SECURITIES INC. KEYBANC CAPITAL MARKETS, A DIVISION OF MCDONALD INVESTMENTS, INC. c/o Bear, Stearns & Co. Inc. 383 Madison Avenue New York, New York 10179
ContractUnderwriting Agreement • January 20th, 2005 • Albemarle Corp • Plastic materials, synth resins & nonvulcan elastomers • New York
Contract Type FiledJanuary 20th, 2005 Company Industry JurisdictionAlbemarle Corporation, a corporation organized and existing under the laws of the Commonwealth of Virginia (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) $325,000,000 in aggregate principal amount of its 5.10% Senior Notes due 2015 (the “Notes”). The Notes are to be issued pursuant to an Indenture, dated as of January 20, 2005, between the Company and The Bank of New York, as Trustee (the “Trustee”), as supplemented by the First Supplemental Indenture, dated of January 20, 2005 (as supplemented, the “Indenture”). Banc of America Securities LLC, UBS Securities LLC and Bear, Stearns & Co. Inc. are acting as representatives (together, the “Representatives”), in connection with the offering and sale of the Notes contemplated herein (the “Offering”).
Senior Notes due 2014 ALBEMARLE CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • December 10th, 2004 • Albemarle Corp • Plastic materials, synth resins & nonvulcan elastomers • New York
Contract Type FiledDecember 10th, 2004 Company Industry JurisdictionAlbemarle Corporation, a corporation organized and existing under the laws of the Commonwealth of Virginia (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) $ in aggregate principal amount of its % Senior Notes due 2014 (the “Notes”). The Notes are to be issued pursuant to an Indenture, dated as of , 2004, between the Company and The Bank of New York, as Trustee (the “Trustee”), as supplemented by the First Supplemental Indenture, dated of , 2004 (as supplemented, the “Indenture”). Banc of America Securities LLC, UBS Securities LLC and Bear, Stearns & Co. Inc. are acting as representatives (together, the “Representatives”), in connection with the offering and sale of the Notes contemplated herein (the “Offering”).
2,200,000 Shares of Common Stock HYPERSPACE COMMUNICATIONS, INC. UNDERWRITING AGREEMENT [SUBJECT TO COMPLETION OF DUE DILIGENCE] July , 2004Underwriting Agreement • July 23rd, 2004 • HyperSpace Communications, Inc. • Services-prepackaged software • New York
Contract Type FiledJuly 23rd, 2004 Company Industry JurisdictionHyperspace Communications, Inc., a corporation organized and existing under the laws of Colorado (the "Company"), confirms its agreement, subject to the terms and conditions set forth herein, with each of the underwriters listed on Exhibit A hereto (collectively, the "Underwriters"), for whom Maxim Group LLC is acting as representative (in such capacity, the "Representative"), to sell and issue to the Underwriters an aggregate of 2,200,000 shares (the "Firm Shares") of its common stock, no par value per share (the "Common Stock"). In addition, the Company proposes to sell to the Underwriters, upon the terms and conditions set forth in Section 2 hereof, an aggregate additional amount of 330,000 shares of Common Stock (the "Additional Shares"). The Firm Shares and any Additional Shares purchased by the Underwriters are referred to herein as the "Shares." The Shares are more fully described in the Registration Statement and Prospectus referred to below. The offering and sale of the Shares
ALARIS Medical, Inc. 7¼% Senior Subordinated Notes due 2011 UNDERWRITING AGREEMENT June 25, 2003Underwriting Agreement • July 14th, 2003 • Alaris Medical Systems Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledJuly 14th, 2003 Company Industry JurisdictionALARIS Medical, Inc., a corporation organized and existing under the laws of Delaware (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of $175,000,000 principal amount of the Company’s 7¼% Senior Subordinated Notes due 2011 (the “Notes”). The Notes will be issued pursuant to the indenture dated as of June 30, as supplemented by the first supplemental indenture (as so supplemented, the “Indenture”), dated as of the Closing Date (as defined below), between the Company and The Bank of New York, as trustee. Bear, Stearns & Co. Inc., Citigroup Global Markets Inc., UBS Securities LLC, CIBC World Markets Corp. and Jefferies & Company, Inc. (the “Representatives”) are acting as co-managers in connection with the offering and sale of the Notes (the “Offering”).